Is irrelevant cleavage the price of antisense efficacy?

Authors
Citation
Ca. Stein, Is irrelevant cleavage the price of antisense efficacy?, PHARM THERA, 85(3), 2000, pp. 231-236
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGY & THERAPEUTICS
ISSN journal
01637258 → ACNP
Volume
85
Issue
3
Year of publication
2000
Pages
231 - 236
Database
ISI
SICI code
0163-7258(200003)85:3<231:IICTPO>2.0.ZU;2-B
Abstract
Antisense oligonucleotides are useful reagents for the suppression of gene expression. Their mechanism of action in eukaryotic cells appears to depend heavily on the activity of RNase H, a ubiquitous enzyme that cleaves the m RNA strand of an RNA-DNA duplex. However, the stringency requirements of RN ase H are very low, and as little as a 5-base complementary region of oligo mer to target may be sufficient to elicit RNase H activity. This would resu lt in scission of nontargeted mRNAs, or what is known as "irrelevant cleava ge." One strategy to reduce RNase H competency that has been employed is mo dification of the oligonucleotide backbone, replacing phosphodiester linkag es with uncharged methylphosphonates, which are not RNase H competent. Anot her strategy involves replacement of deoxyribonucleic acid with 2'-O-alkylr ibonucleic acid. A third strategy, eliminating RNase H dependency entirely, requires activation of RNase P. The relative merits of these strategies wi ll be discussed in the context of selective inhibition of gene function. (C ) 2000 Elsevier Science Inc. All rights reserved.